Using actual case studies, expert speakers will discuss enhancements to test reporting and how these improvements impact the positive predictive value associated with the result.
TORONTO, Ontario (PRWEB) November 12, 2020
Test. Better. With the marked increase in the use of cell-free DNA screening (cfDNA/NIPT) in clinical practice, many non-invasive prenatal test (NIPT) innovations were introduced as screening technology rapidly expanded over the past decade. But which NIPT innovations are likely to tangibly improve outcomes for your practice and patients? Which NIPT innovations improve test performance and increase confidence knowing a screening result is reliable?
This webinar will present a new bioinformatics metric that will support counseling for patients with positive results. Using actual case studies, expert speakers will discuss enhancements to test reporting and how these improvements impact the positive predictive value associated with the result. This comprehensive, evidenced-based webinar will help you: Test. Better.
Join Thomas Westover, MD, FACOG, Chief of Maternal Fetal Medicine and Perinatal Genetics, Capital Health Trenton, NJ; and Jill Rafalko, MS, CGC, LGC, Medical Science Liaison, Integrated Genetics in a live webinar on Wednesday, December 2, 2020 at 1pm EST.
For more information, or to register for this event, visit Test. Better. Enhanced NIPT Reporting for Patients with Positive Results.
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.